Table of Contents

1. Key Highlights:
2. Introduction
3. January 2026 enforcement snapshot
4. Which chemicals and products dominate the filings — and why
5. Why bounty‑hunter suits proliferate under Prop 65
6. Legal defenses and technical strategies that matter
7. Immediate steps after receiving a 60‑day Notice — a prioritized playbook
8. Building a Prop 65 compliance program that reduces future risk
9. Settlement patterns and the true cost of a Prop 65 action
10. Testing, sampling and methodological pitfalls to watch
11. Cross‑regulatory interactions and enforcement overlap
12. Case studies and plausible scenarios
13. Practical considerations for different company sizes and channels
14. What to expect next: enforcement trends and strategic watch points
15. Communications and reputational strategy
16. Checklist: 12 immediate actions for companies served with a Prop 65 60‑day Notice
17. Final perspectives for product teams and legal counsels
18. FAQ

Key Highlights:

• California’s Proposition 65 generated 512 new 60‑day Notices in January 2026, with food and beverage products—especially dietary supplements, meals, seafood and ingredients—accounting for a large share; lead and cadmium remain the most frequently alleged contaminants.
• Beyond heavy metals, claim activity targeted PFAS in seafood and packaged goods, BPS on receipts, phthalates and bisphenols in consumer products, and diethanolamine and mercury in cosmetics; the private-enforcer framework continues to drive volume and settlement pressure.
• Companies should treat a Prop 65 notice as an urgent supply‑chain, testing and legal matter: immediate preservation and testing, exposure assessment against NSRL/MADL thresholds, and a documented compliance program will reduce litigation exposure and settlement costs.

Introduction

California’s Proposition 65 continues to shape product risk management across multiple industries. The statute requires a “clear and reasonable” warning whenever a product exposes a consumer to a chemical listed by the state as a carcinogen or reproductive toxicant, and it permits private parties to enforce the law. That private-enforcement mechanism creates financial incentives for plaintiffs’ firms to issue mass 60‑day Notices of Violation across product categories. January 2026 provides a vivid illustration: 512 new and amended Notices targeted manufacturers, distributors and retailers for alleged failures to provide warnings tied to more than a dozen different chemicals and chemical classes.

This article analyzes the January 2026 enforcement snapshot, explains the chemicals and product types most commonly implicated, outlines the legal and technical defenses available, and presents a practical, prioritized playbook for companies that receive a Prop 65 notice. Industry actors must move beyond reflexive settlement or panicked labeling. Instead, they should adopt a structured approach to testing, supply‑chain management and legal strategy to reduce exposure to penalties, attorney fees and ongoing compliance obligations.

January 2026 enforcement snapshot

January’s 512 Notices reveal several clear patterns in plaintiff activity and enforcement priorities.

• Food and beverage products received the highest concentrations of Notices. Dietary supplements (71 Notices) and meals/dishes (63 Notices) occupied prominent positions, with seafood accounting for at least 63 Notices when PFAS claims are included.
• Lead and cadmium dominated allegations across food categories, appearing in dietary supplements, meals, seafood, ingredients, fruits and vegetables, snacks and plant‑based substitutes.
• PFAS family chemicals—PFOA, PFOS and PFNA—appeared in seafood and a handful of other food notices, reflecting persistent focus on these persistent, bioaccumulative chemicals.
• Consumer products continued to be fertile ground for claims: household items, tools, containers and wearable accessories drew allegations for lead, DEHP/DBP phthalates, chromium (hexavalent) and bisphenols like BPA.
• Thermal receipt paper remained a target; 29 Notices alleged exposure to Bisphenol S (BPS), a common substitute for BPA in thermal paper.
• Cosmetics and personal care notices included allegations of diethanolamine (DEA) and mercury in skin products and makeup.
• Delta‑9‑tetrahydrocannabinol (THC) appeared in 12 notices focused on edibles, signaling continued regulatory risk for cannabis product manufacturers operating in or selling into California.

The California Attorney General’s 60‑Day Notice database provides the raw filings, but the raw numbers understate the commercial and legal impacts. Each Notice triggers internal multi‑disciplinary responses, can lead to litigation after the statutory 60‑day period, and often ends in settlements that require injunctive relief—label changes, product reformulation, supply‑chain audits—plus civil penalties and attorney fees.

Which chemicals and products dominate the filings — and why

The January data clarify where private enforcers are concentrating effort and why certain chemicals keep appearing.

Lead and cadmium: omnipresent in food and consumer goods Lead and cadmium appeared across a broad array of food categories—dietary supplements (71 Notices), meals and dishes (63), seafood (54) and ingredients (42). These heavy metals enter the food chain through multiple pathways: contaminated soil, irrigation water, fertilizers, atmospheric deposition near industrial sites, and migration from processing or packaging equipment. Consumer products also face lead allegations; household items such as ceramic bowls, glassware and metal tools are common sources where coatings, glazes or metal alloys contain detectable lead.

PFAS: seafood and beyond Perfluoroalkyl substances (PFAS) like PFOA, PFOS and PFNA were named in notices tied to seafood products and a smaller number of processed foods. PFAS are persistent, bioaccumulative and can concentrate in marine organisms, especially shellfish and certain fish species. Given the wide regulatory and public health focus on PFAS, private enforcers have made these chemicals a priority.

Phthalates and bisphenols in consumer products Notices implicated phthalates such as DEHP and DBP in tools, containers and wearable accessories, reflecting the continued scrutiny of plasticizers in PVC and soft plastics. Bisphenol S (BPS) surfaced in 29 Notices related to receipts—thermal paper remains a straightforward target for plaintiffs because the alleged exposure pathway (handling receipt paper) is direct and easy to assert.

Diethanolamine and mercury in personal care products Cosmetic and personal care filings included diethanolamine (DEA) in creams, lotions and makeup, and one Notice alleged mercury contamination in a skin product. Mercury in skin‑lightening products is an established public‑health risk and remains a highly actionable target under Prop 65.

THC in edibles Delta‑9‑THC claims in edibles signal a dual regulatory exposure: cannabis remains a complicated landscape of federal prohibition and state authorization, and Prop 65 adds an additional layer of product‑specific exposure risk for edible manufacturers.

Collectively, these patterns show plaintiffs’ focus on products with large consumer footprints and relatively simple alleged exposure pathways, maximizing the likelihood of settlements and statutory fees.

Why bounty‑hunter suits proliferate under Prop 65

Prop 65’s design fosters private enforcement. Three features explain the proliferation of bounty‑hunter actions.

Financial incentives and fee recovery The statute permits recovery of plaintiffs’ attorney fees, creating a financial model that supports repeated filings. Plaintiffs’ firms can issue hundreds of notices, accept a subset of targets for litigation, and achieve settlements that cover fees and penalties. Because civil penalties can reach up to $2,500 per day per violation, settlements that resolve multiple alleged violations quickly become lucrative for plaintiff counsel.

Low barrier to entry A 60‑day Notice must state the alleged violations and the products at issue and be served on the state and the defendant. The procedural threshold for filing notices is low relative to the evidentiary burden required at trial. Plaintiffs can cast a wide net by alleging broadly across product lines and then use the ensuing discovery and negotiation leverage to secure settlements.

Predictable negotiation dynamics Many defendants—especially smaller manufacturers and distributors—seek to avoid the expense and business disruption of litigation. That dynamic empowers plaintiffs to extract monetary penalties and injunctive terms (warnings, reformulation schedules, testing protocols). The combination of recoverable fees, penalties and injunctive relief creates a steady rhythm of notices, negotiations and settlements.

These forces ensure continued high-volume activity, particularly where plaintiffs can assert readily measurable exposures—thermal paper with BPS, supplements with detectable heavy metals, or seafood with PFAS.

Legal defenses and technical strategies that matter

A Prop 65 notice need not become a settlement default. Departments of legal, regulatory and quality teams can often identify defensible positions and technical remedies.

Exposure thresholds: NSRL and MADL Prop 65 does not ban any chemical automatically. For carcinogens, the No Significant Risk Level (NSRL) represents a daily intake that produces no more than one excess cancer case per 100,000 people over a 70‑year lifetime. For reproductive toxicants, the Maximum Allowable Dose Level (MADL) represents a daily exposure level that poses no observable developmental or reproductive effect.

If exposure to the listed chemical from use of the product falls below the NSRL (carcinogens) or the MADL (reproductive toxins), no warning is required. Testing and exposure modelling that demonstrate exposures below these levels are central technical defenses.

Product‑specific exposure analysis The mere presence of a chemical in a product does not automatically translate into a legally significant exposure. Defendants should conduct exposure assessments that consider realistic use patterns, portion sizes, frequency of contact and dermal absorption rates. For food items, that means testing representative samples, calculating probable daily intake, and comparing the results to NSRLs, MADLs and, where applicable, federal action levels or tolerances.

Chain‑of‑custody and sample integrity Testing alone is insufficient if a plaintiff can question the provenance of samples. Maintain rigorous chain‑of‑custody records, preserve product lots, and ensure testing is performed by accredited laboratories using validated methods. Challenge plaintiff testing where methodology or sampling lacks credibility.

Standing and notice defects Plaintiffs must meet statutory notice requirements and other standing prerequisites. Defendants should scrutinize the 60‑day Notice for procedural defects—failure to identify the defendant correctly, incomplete service, or inadequate description of the alleged violations. Those defects can provide early leverage to avoid lawsuit filing or to seek dismissal.

Regulatory timing and list status Prop 65 lists evolve. If the chemical alleged in the Notice was not on the Prop 65 List at the time of the exposure or sale, the defendant can challenge the basis of the claim. Likewise, newly listed chemicals may require firms to reassess products, but retroactive application is limited.

Impossibility and preemption arguments In narrow situations, defendants may assert impossibility—such as when federal law requires the presence of a chemical in a regulated product—or federal preemption. These defenses are fact‑dependent and seldom dispositive, but they provide potential relief in particular contexts (for instance, medical devices or pharmaceuticals under specific FDA mandates).

Commercially driven remedies: warnings, reformulation and supply‑chain controls When exposures exceed thresholds, plaintiffs often seek injunctive relief: warnings, consumer disclosures, or reformulation. Negotiating remedies that focus on realistic mitigation—supplier contracts, ingredient substitution, specific labeling language and compliance timelines—can limit ongoing obligations and costs.

Immediate steps after receiving a 60‑day Notice — a prioritized playbook

Time is the key resource after service of a 60‑day Notice. The statutory clock sets a 60‑day window before plaintiffs may file suit; that window is short but sufficient for an organized response.

1. Preserve evidence and isolate product lots
   • Immediately secure affected SKUs and retain manufacturing and purchase records. Preserve representative samples from multiple production lots. Document the chain of custody for any returned or seized merchandise.
2. Assemble a response team
   • Convene product management, supply‑chain, quality, lab, regulatory and legal contacts. Assign a single point of contact to coordinate with counsel and labs.
3. Review the Notice in detail
   • Check the defendant names, product descriptions, alleged chemical(s), and plaintiff’s requested remedies. Determine whether the Notice was served correctly on all required parties, including the California Attorney General.
4. Conduct targeted testing with accredited labs
   • Prioritize testing methods relevant to the alleged exposure route (oral ingestion, dermal absorption, inhalation). Use labs with ISO/IEC 17025 accreditation or equivalent, and validate methods for the matrix (food, paper, plastic, ceramic glaze).
5. Model exposures and compare to NSRL/MADL
   • For foods: calculate expected daily consumption and resulting dose. For consumer products: model contact frequency and dermal absorption. Compare calculated exposures to NSRLs and MADLs and compile defensible technical memoranda.
6. Assess supply‑chain responsibility
   • Trace ingredient and component sources; request certificates of analysis (CoAs) from suppliers and verify their testing programs. Identify opportunities to require tighter specifications or to change suppliers.
7. Evaluate settlement options versus litigation
   • Small entities may favor settlement; larger manufacturers may opt to litigate marginal claims, especially where testing shows exposures below regulatory thresholds. Counsel should prepare harbor warning language (if applicable), and negotiate penalties and injunctive relief that match the company’s capacity to comply.
8. Consider preemptive compliance actions
   • Where testing shows exposures above thresholds, consider immediate remedial steps: temporary warnings, pulling affected lots, reformulation, or changing packaging.

This playbook focuses resources where they matter most: preserving facts, obtaining reliable data, and creating leverage for negotiation.

Building a Prop 65 compliance program that reduces future risk

A robust Prop 65 compliance program transforms reactive responses into predictable management. Key program elements include:

• Regulatory monitoring and watch lists Maintain a subscription or internal watch for Proposition 65 list updates and California AG notices. Early awareness of new listings permits proactive ingredient substitution and testing.
• Material specifications and supplier controls Set contractual limits for heavy metals, PFAS and restricted chemicals. Require certificates of analysis and supplier attestations. Conduct periodic supplier audits, especially for overseas manufacturers.
• Routine testing program Implement a risk‑based testing regime: more frequent testing for high‑risk categories (seafood, supplements, thermal paper) and targeted spot checks for low‑risk SKUs. Use validated methods and credible labs.
• Label and warning review Standardize warning language and integrate Prop 65 requirements into label approval workflows. Train regulatory and marketing staff to avoid last‑minute label changes that can create compliance gaps.
• Recordkeeping and documentation Preserve test results, exposure assessments, supplier communications and product specifications for at least several years. Documentation is critical both in settlement negotiations and litigation.
• Cross‑functional incident response Create a rapid‑response protocol that includes legal, regulatory, quality and communications functions, with templates for internal notifications, external counsel engagement and select public statements.
• Education and training Train product development, sourcing and quality teams on Prop 65 risk areas so chemical considerations are part of early product design choices.

Companies that invest in these core elements reduce the frequency and severity of claims and increase their negotiating leverage when notices arrive.

Settlement patterns and the true cost of a Prop 65 action

Settlements frequently include three cost components:

1. Civil penalties
   • Up to $2,500 per day per violation. Penalty calculations often reflect the defendant’s perceived ability to pay, the alleged duration of exposure, and the plaintiff’s litigation costs. While plaintiffs rarely obtain the statutory maximum per-day number across all alleged violations, penalties can still be substantial—especially for high‑volume products or prolonged alleged exposure periods.
2. Attorney fees and costs
   • Prop 65 allows plaintiffs to recover reasonable attorneys’ fees. Settlements commonly allocate fees, which can exceed six figures for complex cases.
3. Injunctive relief and compliance costs
   • Required remedies may include consumer warnings (with specified language), reformulation commitments, supplier audits, testing programs, and ongoing monitoring. These obligations create recurring costs and administrative burden.

Example settlement scenarios (illustrative)

• A national retailer facing BPS receipt claims might settle by replacing thermal paper across stores within a set timeframe, paying penalties and fees, and committing to future monitoring—an outcome with immediate and ongoing costs but limited exposure relative to litigation.
• A supplement manufacturer with elevated lead levels in protein powder might agree to reformulate, implement supplier testing requirements, post warnings for existing inventory, and pay penalties and fees. Reformulation costs and market disruption can outweigh the nominal penalties.

The decision to settle or litigate hinges on data quality, exposure modelling, and business calculus. Companies with robust testing and documentation are better positioned to defend without paying unnecessary settlements.

Testing, sampling and methodological pitfalls to watch

Testing and sampling drive Prop 65 outcomes. Plaintiffs may rely on opportunistic sampling or non‑representative methods; defendants must respond with credible, reproducible testing.

Representative sampling Collect multiple samples across production lots and suppliers. Single‑sample results can be challenged as atypical. Statistical sampling plans and lot stratification increase credibility.

Appropriate analytical methods Choose methods validated for the product matrix. For heavy metals, methods like ICP‑MS for lead and cadmium are standard. For PFAS, ensure low‑level detection limits and appropriate extraction techniques. For plasticizers and bisphenols, confirm solvent extraction and instrument parameters.

Exposure modelling assumptions Document assumptions: serving sizes, percent of consumers exposed, frequency of use, and absorption rates. Conservative modelling is defensible, but overstated assumptions are vulnerable in litigation.

Chain‑of‑custody and lab accreditation Use accredited labs, maintain chain‑of‑custody documentation, and retain raw data and instrument logs. Where plaintiff testing exists, conduct split sampling or replicate testing to validate or refute findings.

Methodological disputes often decide early settlement dynamics. Solid science and defensible methods change the negotiation balance.

Cross‑regulatory interactions and enforcement overlap

Prop 65 is state-level, but products also face oversight from federal agencies—the FDA for foods and cosmetics, CPSC for many consumer products, and EPA for environmental contamination. That regulatory mosaic creates complexity:

• Different thresholds and objectives FDA tolerances for contaminants focus on food safety, whereas Prop 65’s NSRL and MADL focus on cancer and reproductive risk at low exposure levels. A product meeting FDA standards can nonetheless trigger Prop 65 exposure claims.
• Parallel investigations and recalls A Prop 65 notice may prompt retailer or distributor actions, even absent federal enforcement, creating supply‑chain disruptions. Conversely, a federal recall can generate additional Prop 65 scrutiny.
• Harmonizing compliance Align testing and risk assessment approaches across regulatory frameworks to reduce duplicative work and contradictory conclusions. For instance, when addressing PFAS in seafood, integrate EPA and state advisories with Prop 65 exposure models.

Legal teams should coordinate across regulatory disciplines to manage conflicting obligations and exploit federal standards where helpful.

Case studies and plausible scenarios

The following hypothetical scenarios illustrate practical responses and outcomes.

Case A: Supplement manufacturer — lead in protein powder A mid‑sized supplement company receives a 60‑day Notice alleging lead in a best‑selling protein powder. The company secures retained inventory, assembles a testing protocol, and conducts analysis across multiple production lots. Results show some lots exceed a conservative exposure benchmark but others fall below. After chain‑of‑custody verification, the company negotiates a settlement that includes: payment of a scaled penalty, implementation of supplier heavy‑metal limits, a quarterly testing program for one year and a narrowed warning obligation limited to lots sold during a specified period. The company also reformulates to source raw material with lower heavy‑metal content, preventing future claims.

Case B: National retailer — BPS on receipts A retailer receives a 60‑day Notice alleging BPS exposure from thermal receipts. The company immediately audits its receipt paper suppliers, conducts testing, and confirms BPS presence in several paper types. The retailer commits to transition to BPA/BPS‑free paper across its national footprint within six months, pays a negotiated penalty and attorney fee allocation, and adopts new procurement specifications to avoid recurrence. The settlement includes a compliance-monitoring provision but no product recall.

Case C: Small cosmetics brand — DEA allegation An indie cosmetics company receives a notice alleging diethanolamine (DEA) in a facial cream. The company’s formula includes a minor emulsifier impurity that can result in trace DEA under certain manufacturing conditions. The brand pauses sales, revises production procedures, completes contaminant testing, and secures supplier guarantees. The matter resolves with a modest penalty, a commitment to implement manufacturing controls, and a requirement to provide periodic testing for a defined period.

Each case shows the value of rapid, science‑based responses and supply‑chain remediation rather than reflexive settlement or defensive brinkmanship.

Practical considerations for different company sizes and channels

Different entities face different tactical choices.

Small brands and startups

• Often lack deep legal budgets, so the practical approach emphasizes quick technical analysis, bargaining for limited injunctive relief, and managed penalties. Early involvement of counsel experienced in Prop 65 can reduce overpayment.

Large manufacturers and retailers

• Can pursue litigated defenses when data supports non‑actionable exposure. Large players also have leverage to negotiate industry‑wide solutions (supplier changes across many brands) and can absorb monitoring obligations.

E‑commerce sellers and marketplaces

• Online platforms and third‑party sellers complicate notice service and liability allocation. Marketplaces should update seller terms to require Prop 65 compliance and maintain documentation for products sold through their platforms.

Importers and supply‑chain managers

• Must enforce specifications and audit foreign suppliers. Many claims trace back to imported raw materials or components; contractual protections and regular testing are essential.

Global brands selling in California

• California’s regime can impose unique obligations not present in other jurisdictions. Companies must consider tailored California programs for labeling, testing and supply‑chain control to reduce market‑specific risk.

What to expect next: enforcement trends and strategic watch points

January 2026’s notice set foreshadows likely continuations and expansions of activity.

• Continued targeting of foods and supplements for heavy metals, given ongoing detection in raw materials and the public scrutiny of supplements.
• PFAS claims will expand beyond seafood into packaging and processed foods as testing capabilities and plaintiff strategies evolve.
• Thermal paper claims will persist as plaintiffs follow bisphenol substitutes and alternative chemistries.
• Cannabis edibles will face heightened scrutiny as state legalization patterns and federal ambiguity intersect with Prop 65’s requirements.
• Plaintiff firms will continue high-volume filings to generate settlement revenue, focusing on products with straightforward exposure narratives.

Companies should monitor California list additions, invest in validated analytical methods for emerging contaminants, and embed Prop 65 risk assessments into product life cycles.

Communications and reputational strategy

Facing a Prop 65 notice raises reputation management questions. Companies should:

• Prepare factual, narrowly tailored external statements if media or retail partners inquire. Avoid overbroad public claims or admissions.
• Notify major customers and channels early if a claim could affect supply or shelf presence; proactive communication reduces surprise delisting or retailer withdrawals.
• Use settlement terms to limit public exposure where feasible (confidentiality provisions can be negotiated, although plaintiffs often resist broad confidentiality for public‑health matters).

Clarity and speed in communication preserve customer trust and reduce downstream disruptions.

Checklist: 12 immediate actions for companies served with a Prop 65 60‑day Notice

1. Secure and preserve representative product samples and related production records.
2. Confirm proper service of the Notice; document dates and recipients.
3. Retain specialized Prop 65 counsel experienced in both litigation and technical defenses.
4. Assemble a cross‑functional response team.
5. Initiate accredited laboratory testing with rigorous chain‑of‑custody.
6. Model exposure against NSRL/MADL thresholds with documented assumptions.
7. Review supplier documentation and request additional CoAs where necessary.
8. Evaluate procedural defects or notice infirmities and consider early motions if warranted.
9. Prepare for negotiation with settlement targets: penalties, injunctive relief and compliance timelines.
10. Consider preemptive mitigations—temporary warnings, inventory holds, or reformulation plans.
11. Notify key commercial partners and internal stakeholders with controlled messaging.
12. Implement or accelerate a long‑term Prop 65 compliance program based on risk assessment.

These steps prioritize evidentiary integrity and preserve defenses that matter in settlement and litigation.

Final perspectives for product teams and legal counsels

Prop 65 remains a powerful enforcement tool in California because its framework combines low procedural barriers for private plaintiffs with high potential penalties and fee recovery. January 2026’s wave of notices emphasizes the importance of cross‑disciplinary preparedness. Successful outcomes rarely hinge on a single action; they require coordinated legal strategy, rigorous science, disciplined supply‑chain management and transparent communication. Companies that treat Prop 65 compliance as an enterprise risk—rather than a regulatory afterthought—will reduce litigation frequency, limit settlement costs and maintain better relationships with retailers and consumers.

FAQ

Q: What exactly triggers a Prop 65 warning requirement? A: A warning is required when use of a product results in a “knowing and intentional” exposure to a chemical listed by the State of California as a carcinogen or reproductive toxicant—unless the exposure is below the relevant regulatory threshold (NSRL for carcinogens or MADL for reproductive toxins).

Q: Who can file a Prop 65 lawsuit? A: Private individuals and organizations can file suit after serving a 60‑day Notice on the defendant and specified public officials. The Attorney General of California may also bring enforcement actions. Private plaintiffs can recover attorney fees and seek civil penalties and injunctive relief.

Q: What is a 60‑day Notice and why is it important? A: The 60‑day Notice informs the defendant and the state of an alleged Prop 65 violation and starts a 60‑day period before a private plaintiff may file suit. The Notice sets out the claims and targeted products. Proper analysis and action during the 60‑day window often determine whether the matter settles or proceeds to litigation.

Q: What defenses exist if my product contains a listed chemical? A: Common defenses include demonstrating that exposure is below the NSRL/MADL thresholds, challenging the plaintiff’s sampling or testing methods, identifying procedural defects in the 60‑day Notice, and showing the chemical was not listed at the time of the exposure. Defenses are fact‑dependent and require credible testing and documentation.

Q: Does Prop 65 apply even if the product meets federal standards? A: Yes. Prop 65 operates independently of federal standards. A product compliant with FDA or other federal requirements can still trigger Prop 65 obligations if exposures exceed California’s thresholds.

Q: How are penalties calculated? A: Penalties can be up to $2,500 per day per violation. Calculations typically depend on the duration of the alleged violation, number of affected products or lots, and settlement negotiations. Penalties are often a negotiated component of settlement agreements.

Q: What should a small company do first after receiving a notice? A: Immediately preserve product samples and documentation, secure legal counsel with Prop 65 experience, and conduct prioritized testing to assess exposure. Early, well-documented testing can substantially improve settlement positions.

Q: Can I use a general consumer warning to satisfy Prop 65? A: Prop 65 requires “clear and reasonable” warnings. Safe-harbor warning language exists and specifying the chemical name and whether it causes cancer or reproductive harm is common. Legal counsel should review any proposed warning to ensure it meets current guidance and specific settlement terms.

Q: Are there industry best practices to avoid future notices? A: Yes. Maintain supplier specifications and audits, implement routine testing programs, monitor Prop 65 list updates, integrate chemical risk assessment into product development, and standardize label and warning approval processes.

Q: Where can I find the list of Prop 65 chemicals and filed notices? A: The Office of Environmental Health Hazard Assessment (OEHHA) maintains the Prop 65 List of chemicals, and the California Attorney General’s website hosts the 60‑Day Notice search tool with details on recent filings.

Q: How long do settlement obligations usually last? A: Settlements can include short-term compliance obligations (months) and longer monitoring or testing commitments (one to several years). The duration depends on the remediation required and the scope of the alleged violation.

Q: Is litigation ever the better course than settlement? A: Litigation can be appropriate when testing and exposure modeling demonstrate non‑actionable exposures, or where a defendant wants to set precedent. Litigation carries costs and uncertainty; companies with strong evidence and resources may pursue it to avoid recurring settlements.

Q: Will a Prop 65 warning harm sales? A: Impacts vary. Some consumers interpret warnings as a signal of risk; others see them as ubiquitous compliance marks. Clear consumer communication and rapid remediation often mitigate reputational impacts.

Q: How should retailers manage incoming notices for products they sell? A: Retailers should require suppliers to provide Prop 65 compliance documentation, maintain reserve inventory for testing, and coordinate with legal counsel. Large retailers often negotiate with plaintiffs and suppliers to manage risk and continuity of supply.

Q: What emerging chemical trends should companies watch? A: Expect ongoing focus on PFAS, evolving scrutiny of bisphenol substitutes and plasticizers, expanding attention to heavy metals in supplements and botanical ingredients, and continuing inspection of cannabis products. Monitoring additions to the Prop 65 List is critical.